Tirzepatide, a novel medication, is generating considerable excitement within the healthcare community. It operates differently from traditional diabetes medications, targeting two receptors involved in sugar regulation and appetite . Initial studies have demonstrated impressive efficacy in controlling blood sugar in individuals with type 2 diabete